SELECT Salutation, Firstname, Lastname, FUR_Profile_Image FROM facultyProfile WHERE PersonID = 330
Medscape Medical News profiles Susan Band Horwitz, Ph.D., who will receive the Eighth American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research on April 3. Dr. Horwitz identified the mechanism for action for the cancer chemotherapeutic drug Taxol, which has been used to treat over a million people with ovarian, breast or lung cancer. In addition to detailing her lab's Taxol discovery, Dr. Horwitz emphasizes the importance of mentoring young scientists, her concern that low NIH funding levels are discouraging to young scientists, and the need to maintain a sense of curiosity throughout one's career. Dr. Horwitz is the Rose C. Falkenstein Professor of Cancer Research and co-chair of molecular pharmacology at Einstein and associate director for experimental therapeutics at the Albert Einstein Cancer Center. (Free subscription required.) (Wednesday, February 23, 2011)
More coverage on this storyMedial News Today
CR magazine (a publication of the American Association for Cancer Research) profiles Susan Band Horwitz, Ph.D. on her role in evaluating and championing Taxol, the revolutionary cancer drug now widely used to treat breast and ovarian cancers. In the profile story, Dr. Horwitz details how she chose the field of pharmacology, her excitement in discovering the mechanism of action of Taxol, and her active role in supporting its development. Dr. Horwitz is distinguished professor and co-chair of molecular pharmacology and the Rose C. Fleckenstein Chair in Cancer Research. (Wednesday, February 17, 2010)
WABC-TV profiles Dr. Susan Band Horwitz for her research on how the drug Taxol attacks cancer cells. Dr. Horwitz, a Distinguished Professor and co-chair of molecular pharmacology, is the recent recipient of a Medal of Honor Award from the American Cancer Society. (Wednesday, December 10, 2008) read more...
More coverage on this storySee other stories featuring Dr. Horwitz
WCBS-AM 880 anchor Pat Carroll interviews Dr. Susan Band Horwitz, Falkenstein Professor of Cancer Research and co-chair of molecular pharmacology at Einstein, on her groundbreaking breast cancer research as part of October's National Breast Cancer Awareness Month. Dr. Horwitz discovered the mechanism of action of the cancer drug Taxol, derived from the yew tree. She is currently researching other naturally occurring cancer fighters. The interview was part of the Women in Business Report. (Friday, October 17, 2008) hear audio...